Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.

Comparing Gross Profit Growth: Lantheus vs. Amneal (2014-2023)

__timestampAmneal Pharmaceuticals, Inc.Lantheus Holdings, Inc.
Wednesday, January 1, 2014449634000125519000
Thursday, January 1, 2015499226000135522000
Friday, January 1, 2016597455000137780000
Sunday, January 1, 2017526178000162135000
Monday, January 1, 2018716403000174885000
Tuesday, January 1, 2019352997000174811000
Wednesday, January 1, 2020628393000138761000
Friday, January 1, 2021768973000187695000
Saturday, January 1, 2022784708000581703000
Sunday, January 1, 2023820565000709543000
Loading chart...

Cracking the code

A Tale of Two Companies: Gross Profit Trends from 2014 to 2023

In the competitive landscape of pharmaceuticals, understanding financial performance is crucial. This analysis delves into the gross profit trends of Lantheus Holdings, Inc. and Amneal Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Amneal Pharmaceuticals consistently outperformed Lantheus Holdings in terms of gross profit. However, Lantheus Holdings showed remarkable growth, with its gross profit surging by over 460% from 2014 to 2023, reaching approximately $710 million. In contrast, Amneal Pharmaceuticals experienced a more modest growth of around 82% during the same period, peaking at about $820 million in 2023. This data highlights the dynamic shifts in the pharmaceutical industry, where strategic decisions and market conditions can significantly impact financial outcomes. As we move forward, these trends offer valuable insights into the evolving strategies of these industry players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025